Literature DB >> 3994910

Human tumour cell lines established in vitro from tumours after long-term passage as nude mouse xenografts. Comparative fingerprinting of their concanavalin-A acceptor glycoproteins.

J Walton, D Winterbourne, A Fiennes, P Harris, J Hermon-Taylor, A Grant.   

Abstract

Two human colon cancer xenografts (EC and AC) were established in tissue culture only after long-term passage in nude mice. Earlier attempts to establish cell lines were unsuccessful. The epithelioid cells retain their tumourigenicity after in vitro growth, giving rise to tumours with a take rate of 60-80%. After reimplantation, the xenografts retain a similar morphology to that of the original human tumours. Both cell lines show human karyology. Comparative mapping of Concanavalin-A acceptor glycoproteins provides a fingerprint characteristic of each cell line. These glycoprotein patterns are similar to those shown by HT-29, an established colon cancer cell line.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994910      PMCID: PMC1977045          DOI: 10.1038/bjc.1985.102

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Establishment of epithelial cell line MDA-MB-157 from metastatic pleural effusion of human breast carcinoma.

Authors:  R K Young; R M Cailleau; B Mackay; W J Reeves
Journal:  In Vitro       Date:  1974 Jan-Feb

3.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

4.  Glycoprotein detection in nitrocellulose transfers of electrophoretically separated protein mixtures using concanavalin A and peroxidase: application to arenavirus and flavivirus proteins.

Authors:  J C Clegg
Journal:  Anal Biochem       Date:  1982-12       Impact factor: 3.365

5.  Transplantation of human renal cell carcinoma to the nude mice: as an intermediate of in vivo and in vitro studies.

Authors:  Y Katsuoka; S Baba; M Hata; H Tazaki
Journal:  J Urol       Date:  1976-04       Impact factor: 7.450

6.  The use of Tween 20 as a blocking agent in the immunological detection of proteins transferred to nitrocellulose membranes.

Authors:  B Batteiger; W J Newhall; R B Jones
Journal:  J Immunol Methods       Date:  1982-12-30       Impact factor: 2.303

7.  In vivo induction of neoplastic growth in nude mouse connective tissue adjacent to xenografted human tumors.

Authors:  H J Staab; H Heilbronner; M Schrader; F A Anderer
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

8.  Stability of the glycoproteins from a primary human pancreatic carcinoma during cell culture and in vivo passage in nude mice.

Authors:  G Koch; M J Smith; A G Grant; J Hermon-Taylor
Journal:  Br J Cancer       Date:  1983-04       Impact factor: 7.640

9.  Establishment and characterization of primary human pancreatic carcinoma in continuous cell culture and in nude mice.

Authors:  A G Grant; D Duke; J Hermon-Taylor
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

10.  Concanavalin A acceptor glycoproteins: a new type of marker for the classification of tumour cells.

Authors:  G L Koch; M J Smith
Journal:  Br J Cancer       Date:  1983-04       Impact factor: 7.640

View more
  2 in total

1.  Establishment and characterization of a human colon cancer cell line, OUMS-23, from a patient with familial adenomatous polyposis.

Authors:  M Miyazaki; S Tsuboi; K Mihara; T Kosaka; K Fukaya; K Kino; M Mori; M Namba
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 2.  Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma.

Authors:  J M Jessup; P Thomas
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.